Welcome!

News Feed Item

Mania Global Clinical Trials Review, H2, 2014

NEW YORK, Aug. 5, 2014 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Mania Global Clinical Trials Review, H2, 2014

http://www.reportlinker.com/p02256138/Mania-Global-Clinical-Trials-Review-H2-2014.html

Mania Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, "Mania Global Clinical Trials Review, H2, 2014" provides data on the Mania clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Mania. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Mania. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6

Mania 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Mania to Central Nervous System Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Mania to Central Nervous System Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19

Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Mania 25
Subjects Recruited Over a Period of Time 27
Clinical Trials by Sponsor Type 28
Prominent Sponsors 29
Top Companies Participating in Mania Therapeutics Clinical Trials 30
Prominent Drugs 31
Clinical Trial Profiles 32
Clinical Trial Overview of Top Companies 32
AstraZeneca PLC 32

Clinical Trial Overview of AstraZeneca PLC 32
Pfizer Inc. 34
Clinical Trial Overview of Pfizer Inc. 34
Abbott Laboratories 35
Clinical Trial Overview of Abbott Laboratories 35
Johnson & Johnson 36
Clinical Trial Overview of Johnson & Johnson 36
Otsuka Holdings Co., Ltd. 37
Clinical Trial Overview of Otsuka Holdings Co., Ltd. 37
Eli Lilly and Company 38
Clinical Trial Overview of Eli Lilly and Company 38
Richter Gedeon Nyrt. 39

Clinical Trial Overview of Richter Gedeon Nyrt. 39
Actavis plc 40
Clinical Trial Overview of Actavis plc 40
Bristol-Myers Squibb Company 41
Clinical Trial Overview of Bristol-Myers Squibb Company 41
Bluefish Pharmaceuticals AB 42
Clinical Trial Overview of Bluefish Pharmaceuticals AB 42
Clinical Trial Overview of Top Institutes / Government 43
Massachusetts General Hospital 43
Clinical Trial Overview of Massachusetts General Hospital 43
University of Cincinnati 44
Clinical Trial Overview of University of Cincinnati 44
Mclean Hospital 45
Clinical Trial Overview of Mclean Hospital 45
University of Leipzig 46

Clinical Trial Overview of University of Leipzig 46
Cedars-Sinai Medical Center 47
Clinical Trial Overview of Cedars-Sinai Medical Center 47
University of British Columbia 48
Clinical Trial Overview of University of British Columbia 48
Eunice Kennedy Shriver National Institute of Child Health and Human Development 49
Clinical Trial Overview of Eunice Kennedy Shriver National Institute of Child Health and Human Development 49
National Institute of Mental Health 50
Clinical Trial Overview of National Institute of Mental Health 50
University of Texas Southwestern Medical Center at Dallas 51
Clinical Trial Overview of University of Texas Southwestern Medical Center at Dallas 51
Mashhad University of Medical Sciences 52
Clinical Trial Overview of Mashhad University of Medical Sciences 52
Five Key Clinical Profiles 53
Appendix 114
Abbreviations 114
Definitions 114
Research Methodology 115
Secondary Research 115
About GlobalData 116
Contact Us 116
Disclaimer 116
Source 116

List of Tables

Mania Therapeutics, Global, Clinical Trials by Region, 2014* 7
Mania Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Mania Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Mania Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Mania Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Mania Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Mania Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014* 13
Mania Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014* 14
Proportion of Mania to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 15
Mania Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Mania Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Mania to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 18
Mania Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Mania Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Mania Therapeutics, Global, Clinical Trials by Phase, 2014* 21
Mania Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22

Mania Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Mania Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Mania Therapeutics, Global, Withdrawn Clinical Trials, 2014* 25
Mania Therapeutics, Global, Terminated Clinical Trials, 2014* 26
Mania Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 27
Mania Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 28
Mania Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 29
Mania Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 30
Mania Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 31
Mania Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2014* 32
Mania Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014* 34
Mania Therapeutics Clinical Trials Market, Global, Clinical Trials by Abbott Laboratories, 2014* 35
Mania Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2014* 36
Mania Therapeutics Clinical Trials Market, Global, Clinical Trials by Otsuka Holdings Co., Ltd., 2014* 37

Mania Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2014* 38
Mania Therapeutics Clinical Trials Market, Global, Clinical Trials by Richter Gedeon Nyrt., 2014* 39
Mania Therapeutics Clinical Trials Market, Global, Clinical Trials by Actavis plc, 2014* 40
Mania Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2014* 41
Mania Therapeutics Clinical Trials Market, Global, Clinical Trials by Bluefish Pharmaceuticals AB, 2014* 42
Mania Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2014* 43
Mania Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Cincinnati, 2014* 44
Mania Therapeutics Clinical Trials Market, Global, Clinical Trials by Mclean Hospital, 2014* 45
Mania Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Leipzig, 2014* 46
Mania Therapeutics Clinical Trials Market, Global, Clinical Trials by Cedars-Sinai Medical Center, 2014* 47
Mania Therapeutics Clinical Trials Market, Global, Clinical Trials by University of British Columbia, 2014* 48

Mania Therapeutics Clinical Trials Market, Global, Clinical Trials by Eunice Kennedy Shriver National Institute of Child Health and Human Development, 2014* 49
Mania Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Mental Health, 2014* 50
Mania Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Texas Southwestern Medical Center at Dallas, 2014* 51
Mania Therapeutics Clinical Trials Market, Global, Clinical Trials by Mashhad University of Medical Sciences, 2014* 52

List of Figures

Mania Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Mania Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Mania Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Mania Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Mania Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Mania Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Mania Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2014* 13
Mania Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014* 14
Proportion of Mania to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 15
Mania Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Mania Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Mania to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 18
Mania Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Mania Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20

Mania Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21
Mania Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22
Mania Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Mania Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Mania Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 27
Mania Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 28
Mania Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 29
Mania Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 30
Mania Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 31
GlobalData Methodology 115

To order this report: Mania Global Clinical Trials Review, H2, 2014
http://www.reportlinker.com/p02256138/Mania-Global-Clinical-Trials-Review-H2-2014.html

__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
The Internet of Things can drive efficiency for airlines and airports. In their session at @ThingsExpo, Shyam Varan Nath, Principal Architect with GE, and Sudip Majumder, senior director of development at Oracle, will discuss the technical details of the connected airline baggage and related social media solutions. These IoT applications will enhance travelers' journey experience and drive efficiency for the airlines and the airports. The session will include a working demo and a technical d...
SYS-CON Events announced today that Commvault, a global leader in enterprise data protection and information management, has been named “Bronze Sponsor” of SYS-CON's 19th International Cloud Expo, which will take place on November 1–3, 2016, at the Santa Clara Convention Center in Santa Clara, CA. Commvault is a leading provider of data protection and information management solutions, helping companies worldwide activate their data to drive more value and business insight and to transform moder...
The Transparent Cloud-computing Consortium (abbreviation: T-Cloud Consortium) will conduct research activities into changes in the computing model as a result of collaboration between "device" and "cloud" and the creation of new value and markets through organic data processing High speed and high quality networks, and dramatic improvements in computer processing capabilities, have greatly changed the nature of applications and made the storing and processing of data on the network commonplace.
DevOps at Cloud Expo – being held November 1-3, 2016, at the Santa Clara Convention Center in Santa Clara, CA – announces that its Call for Papers is open. Born out of proven success in agile development, cloud computing, and process automation, DevOps is a macro trend you cannot afford to miss. From showcase success stories from early adopters and web-scale businesses, DevOps is expanding to organizations of all sizes, including the world's largest enterprises – and delivering real results. Am...
SYS-CON Events announced today that Bsquare has been named “Silver Sponsor” of SYS-CON's @ThingsExpo, which will take place on November 1–3, 2016, at the Santa Clara Convention Center in Santa Clara, CA. For more than two decades, Bsquare has helped its customers extract business value from a broad array of physical assets by making them intelligent, connecting them, and using the data they generate to optimize business processes.
I'm a lonely sensor. I spend all day telling the world how I'm feeling, but none of the other sensors seem to care. I want to be connected. I want to build relationships with other sensors to be more useful for my human. I want my human to understand that when my friends next door are too hot for a while, I'll soon be flaming. And when all my friends go outside without me, I may be left behind. Don't just log my data; use the relationship graph. In his session at @ThingsExpo, Ryan Boyd, Engi...
SYS-CON Events announced today that Pulzze Systems will exhibit at the 19th International Cloud Expo, which will take place on November 1–3, 2016, at the Santa Clara Convention Center in Santa Clara, CA. Pulzze Systems, Inc. provides infrastructure products for the Internet of Things to enable any connected device and system to carry out matched operations without programming. For more information, visit http://www.pulzzesystems.com.
Fact is, enterprises have significant legacy voice infrastructure that’s costly to replace with pure IP solutions. How can we bring this analog infrastructure into our shiny new cloud applications? There are proven methods to bind both legacy voice applications and traditional PSTN audio into cloud-based applications and services at a carrier scale. Some of the most successful implementations leverage WebRTC, WebSockets, SIP and other open source technologies. In his session at @ThingsExpo, Da...
SYS-CON Events announced today that Secure Channels will exhibit at the 19th International Cloud Expo, which will take place on November 1–3, 2016, at the Santa Clara Convention Center in Santa Clara, CA. The bedrock of Secure Channels Technology is a uniquely modified and enhanced process based on superencipherment. Superencipherment is the process of encrypting an already encrypted message one or more times, either using the same or a different algorithm.
Traditional on-premises data centers have long been the domain of modern data platforms like Apache Hadoop, meaning companies who build their business on public cloud were challenged to run Big Data processing and analytics at scale. But recent advancements in Hadoop performance, security, and most importantly cloud-native integrations, are giving organizations the ability to truly gain value from all their data. In his session at 19th Cloud Expo, David Tishgart, Director of Product Marketing ...
Almost two-thirds of companies either have or soon will have IoT as the backbone of their business in 2016. However, IoT is far more complex than most firms expected. How can you not get trapped in the pitfalls? In his session at @ThingsExpo, Tony Shan, a renowned visionary and thought leader, will introduce a holistic method of IoTification, which is the process of IoTifying the existing technology and business models to adopt and leverage IoT. He will drill down to the components in this fra...
The vision of a connected smart home is becoming reality with the application of integrated wireless technologies in devices and appliances. The use of standardized and TCP/IP networked wireless technologies in line-powered and battery operated sensors and controls has led to the adoption of radios in the 2.4GHz band, including Wi-Fi, BT/BLE and 802.15.4 applied ZigBee and Thread. This is driving the need for robust wireless coexistence for multiple radios to ensure throughput performance and th...
SYS-CON Events announced today the Kubernetes and Google Container Engine Workshop, being held November 3, 2016, in conjunction with @DevOpsSummit at 19th Cloud Expo at the Santa Clara Convention Center in Santa Clara, CA. This workshop led by Sebastian Scheele introduces participants to Kubernetes and Google Container Engine (GKE). Through a combination of instructor-led presentations, demonstrations, and hands-on labs, students learn the key concepts and practices for deploying and maintainin...
Enterprise IT has been in the era of Hybrid Cloud for some time now. But it seems most conversations about Hybrid are focused on integrating AWS, Microsoft Azure, or Google ECM into existing on-premises systems. Where is all the Private Cloud? What do technology providers need to do to make their offerings more compelling? How should enterprise IT executives and buyers define their focus, needs, and roadmap, and communicate that clearly to the providers?
SYS-CON Events announced today that SoftLayer, an IBM Company, has been named “Gold Sponsor” of SYS-CON's 18th Cloud Expo, which will take place on June 7-9, 2016, at the Javits Center in New York, New York. SoftLayer, an IBM Company, provides cloud infrastructure as a service from a growing number of data centers and network points of presence around the world. SoftLayer’s customers range from Web startups to global enterprises.